Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises West of England on the acquisition of Nordisk Marinförsäkring
Mandate

Vinge advises West of England on the acquisition of Nordisk Marinförsäkring

May 13, 2025

Vinge has advised The West of England Ship Owners Mutual Insurance Association (Luxembourg), a leading insurance provider to the global maritime industry, on the acquisition of all remaining shares in Nordisk Marinförsäkring AB (“Nordisk Marinförsäkring”). West of England has been a shareholder of Nordisk Marinförsäkring since 2020. This is a strategic acquisition that enables West of England to diversify its business and broaden the services and products it provides to its members and to the maritime market as a whole.

Nordisk Marinförsäkring specialises in niche products within the marine insurance field and has a strong reputation among shipowners, freight forwarders and brokers for its innovative and high-quality products.

Vinge's team consisted of Viveka Classon and Olivia Carlsten (Corporate Insurance), Filip Öhrner and Alex Forsberg (M&A) as well as Daniel Wendelsson and Martin Hammarskiöld (FDI).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025